ArticleBMC pharmacology & toxicology2025

Multi-target antidiabetic therapy with voglibose, ubiquinone, and tempol: synergistic effects on liver and skeletal muscle in experimental type 2 diabetes.

Öznur Tufan Akarslan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.